Monitoring vaccine safety using the vaccine safety Datalink: Assessing capacity to integrate data from Immunization Information systems
HC Groom, B Crane, AL Naleway, E Weintraub…�- Vaccine, 2022 - Elsevier
HC Groom, B Crane, AL Naleway, E Weintraub, MF Daley, K Wain, MB Kurilo…
Vaccine, 2022•ElsevierAbstract Background The Vaccine Safety Datalink (VSD) uses vaccination data from
electronic health records (EHR) at eight integrated health systems to monitor vaccine safety.
Accurate capture of data from vaccines administered outside of the health system is critical
for vaccine safety research, especially for COVID-19 vaccines, where many are
administered in non-traditional settings. However, timely access and inclusion of data from
Immunization Information Systems (IIS) into VSD safety assessments is not well understood�…
electronic health records (EHR) at eight integrated health systems to monitor vaccine safety.
Accurate capture of data from vaccines administered outside of the health system is critical
for vaccine safety research, especially for COVID-19 vaccines, where many are
administered in non-traditional settings. However, timely access and inclusion of data from
Immunization Information Systems (IIS) into VSD safety assessments is not well understood�…
Background
The Vaccine Safety Datalink (VSD) uses vaccination data from electronic health records (EHR) at eight integrated health systems to monitor vaccine safety. Accurate capture of data from vaccines administered outside of the health system is critical for vaccine safety research, especially for COVID-19 vaccines, where many are administered in non-traditional settings. However, timely access and inclusion of data from Immunization Information Systems (IIS) into VSD safety assessments is not well understood.
Methods
We surveyed the eight data-contributing VSD sites to assess: 1) status of sending data to IIS; 2) status of receiving data from IIS; and 3) integration of IIS data into the site EHR. Sites reported separately for COVID-19 vaccination to capture any differences in capacity to receive and integrate data on COVID-19 vaccines versus other vaccines.
Results
All VSD sites send data to and receive data from their state IIS. All eight sites (100%) routinely integrate IIS data for COVID-19 vaccines into VSD research studies. Six sites (75%) also routinely integrate all other vaccination data; two sites integrate data from IIS following a reconciliation process, which can result in delays to integration into VSD datasets.
Conclusions
COVID-19 vaccines are being administered in a variety of non-traditional settings, where IIS are commonly used as centralized reporting systems. All eight VSD sites receive and integrate COVID-19 vaccine data from IIS, which positions the VSD well for conducting quality assessments of vaccine safety. Efforts to improve the timely receipt of all vaccination data will improve capacity to conduct vaccine safety assessments within the VSD.
Elsevier